Role of angiogenesis inhibitors in the treatment of lung cancer

被引：0
|
作者：
Schiller, JH [1 ]
机构：
[1] Univ Wisconsin, Madison, WI 53706 USA
来源：
LUNG CANCER | 2004年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S2 / S3
页数：2
相关论文
共 50 条
  • [21] The role of angiogenesis inhibitors associated with tyrosine kinase inhibitors in the first-line treatment for EGFR-mutated advanced lung cancer
    Motta-Guerrero, Rodrigo
    Recondo, Gonzalo
    Cardona, Andres
    Corrales, Luis
    Arnao, Veronica
    Failoc-Rojas, Virgilio E.
    Aliaga, Carlos
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 196
  • [22] Angiogenesis inhibitors for the treatment of ovarian cancer
    Gaitskell, Kezia
    Martinek, Igor
    Bryant, Andrew
    Kehoe, Sean
    Nicum, Shibani
    Morrison, Jo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (09):
  • [23] Angiogenesis inhibitors in the treatment of prostate cancer
    Hwang, Clara
    Heath, Elisabeth I.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2010, 3
  • [24] Angiogenesis inhibitors in the treatment of colorectal cancer
    Iqbal, S
    Lenz, HJ
    SEMINARS IN ONCOLOGY, 2004, 31 (06) : 10 - 16
  • [25] Angiogenesis inhibitors in the treatment of prostate cancer
    Clara Hwang
    Elisabeth I Heath
    Journal of Hematology & Oncology, 3
  • [26] Angiogenesis inhibitors in the treatment of prostate cancer
    Kluetz, Paul G.
    Figg, William D.
    Dahut, William L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (02) : 233 - 247
  • [27] The Role of Angiogenesis in Cancer Treatment
    Rajabi, Mehdi
    Mousa, Shaker A.
    BIOMEDICINES, 2017, 5 (02)
  • [28] Angiogenesis inhibitors - A promising role in cancer therapy
    Hui, YF
    Ignoffo, RJ
    CANCER PRACTICE, 1998, 6 (01) : 60 - 62
  • [29] Angiogenesis and antiangiogenic treatment in lung cancer
    J. F. Morère
    J. M. Brechot
    R. Etessami
    Targeted Oncology, 2006, 1 : 215 - 219
  • [30] Angiogenesis and antiangiogenic treatment in lung cancer
    Morere, J. F.
    Brechot, J. M.
    Etessami, R.
    TARGETED ONCOLOGY, 2006, 1 (04) : 215 - 219
12345